Evidence map›Paper›PMID 24117140›Full record

ArticleBritish journal of pharmacology2014

Bitter tasting compounds dilate airways by inhibiting airway smooth muscle calcium oscillations and calcium sensitivity.

Xiahui Tan, Michael J Sanderson

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 85 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Molecular mechanism of bitter taste receptor agonist-mediated relaxation of airway smooth muscle.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Bitter Taste Receptors in the Airway Cells Functions.Handbook of experimental pharmacology · 2022
    Article
  12. Article
  13. Article
  14. An update on extra-oral bitter taste receptors.Journal of translational medicine · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Possible Beneficial Actions of Caffeine in SARS-CoV-2.International journal of molecular sciences · 2021
    Review
  19. Article
  20. Can GPCRs Be Targeted to Control Inflammation in Asthma?Advances in experimental medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Xiahui TanDepartment of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, MA, USA.
Michael J Sanderson
University of Massachusetts Chan Medical School · US

Funding

A multi-scale approach to airway hyperresponsiveness: from molecule to organR01HL103405 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BATES, JASON HT, LAUZON, ANNE-MARIE · 2010 to 2013
$3.6M
NHLBI NIH HHS HL103405NHLBI NIH HHS R01 HL103405
6 · The paper itself

Abstract

background and purposeWhile selective, bitter tasting, TAS2R agonists can relax agonist-contracted airway smooth muscle (ASM), their mechanism of action is unclear. However, ASM contraction is regulated by Ca²⁺ signalling and Ca²⁺ sensitivity. We have therefore investigated how the TAS2R10 agonists chloroquine, quinine and denotonium regulate contractile agonist-induced Ca²⁺ signalling and sensitivity. EXPERIMENTAL APPROACH: Airways in mouse lung slices were contracted with either methacholine (MCh) or 5HT and bronchodilation assessed using phase-contrast microscopy. Ca²⁺ signalling was measured with 2-photon fluorescence microscopy of ASM cells loaded with Oregon Green, a Ca²⁺-sensitive indicator (with or without caged-IP₃). Effects on Ca²⁺ sensitivity were assessed on lung slices treated with caffeine and ryanodine to permeabilize ASM cells to Ca²⁺ . KEY

resultsThe TAS2R10 agonists dilated airways constricted by either MCh or 5HT, accompanied by inhibition of agonist-induced Ca²⁺ oscillations. However, in non-contracted airways, TAS2R10 agonists, at concentrations that maximally dilated constricted airways, did not evoke Ca²⁺ signals in ASM cells. Ca²⁺ increases mediated by the photolysis of caged-IP₃ were also attenuated by chloroquine, quinine and denotonium. In Ca²⁺-permeabilized ASM cells, the TAS2R10 agonists dilated MCh- and 5HT-constricted airways. CONCLUSIONS AND IMPLICATIONS: TAS2R10 agonists reversed bronchoconstriction by inhibiting agonist-induced Ca²⁺ oscillations while simultaneously reducing the Ca²⁺ sensitivity of ASM cells. Reduction of Ca²⁺ oscillations may be due to inhibition of Ca²⁺ release through IP₃ receptors. Further characterization of bronchodilatory TAS2R agonists may lead to the development of novel therapies for the treatment of bronchoconstrictive conditions.

Indexed as

Airway ResistanceAnimalsBronchodilator AgentsCaffeineCalcium Channel BlockersCalcium SignalingChloroquineDrug ResistanceFemaleInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsIn Vitro TechniquesLungMiceMice, Inbred BALB CMuscle RelaxationBronchodilator AgentsCaffeineCalcium Channel BlockersChloroquineInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsPhosphodiesterase InhibitorsQuaternary Ammonium CompoundsQuinineReceptors, G-Protein-CoupledRyanodineTas2r107 protein, mouse2-photon microscopyasthmamouse lung sliceTAS2Rβ2-adrenergic receptor agonists

Identifiers

PMID24117140
PMCPMC3969078
OpenAlexW1499742104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.